Company intelligence / Profile preview

Cathay Biotech

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Cathay Biotech develops, manufactures, and sells innovative bio-based materials using proprietary synthetic biology platforms. The company has successfully commercialized several key products including long-chain diacids, pentamethylene diamine, and a range of high-performance polyamides used in diverse industries such as textiles, automotive, electronics, energy storage/hydrogen transport solutions. It operates large-scale production facilities in China with global sales presence. The business model centers on sustainable alternatives to petrochemicals through advanced fermentation processes.

Industry: Non-Drug Biotech

Partnerships

Partnership with Korean firm “3P.COM” on hydrogen storage tank development using continuous fiber-reinforced composites

Beyond the preview

Go deeper on Cathay Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathay Biotech.

Explore the full profile